Redwood Scientific Technologies Receives Conditional Approval from IRB/CIRB for Groundbreaking Clinical Studies

Rhea-AI Summary

Redwood Scientific Technologies (RSCI OTC PINK) has secured conditional approval from the Institutional Review Board (IRB)/Central Institutional Review Board (CIRB) for groundbreaking clinical studies on a new Oral Thin Film Strip to address nicotine addiction in vape devices and TBX FREE for traditional cigarettes. This milestone signifies a significant advancement in Redwood's efforts to combat nicotine addiction and marks a crucial step forward in bringing nicotine-free solutions to the market.

Positive

• Conditional approval from IRB/CIRB opens doors for groundbreaking clinical studies
• Potential to be a pioneer in the market with a nicotine-free solution for addiction to nicotine in e-cigarettes or vape devices
• CEO's dedication to accelerating product development and market availability

Negative

• None.

NEW YORK, Nov. 14, 2023 /PRNewswire/ -- Redwood Scientific Technologies ( RSCI OTC PINK ) is pleased to announce that, as of 11-13-2023 at 10:42 AM, it has secured conditional approval from the Institutional Review Board (IRB)/Central Institutional Review Board (CIRB). This milestone marks a significant advancement in Redwood's ongoing efforts towards clinical study work, aiming to develop and introduce an Oral Thin Film Strip to address nicotine addiction in vape devices.

Redwood Scientific Technologies Receives Conditional Approval from IRB/CIRB for Groundbreaking Clinical Studies

The conditional IRB approval not only paves the way for the study on Redwood's innovative product for nicotine addiction in vape devices but also extends to a study on TBX FREE, the company's primary product designed to combat nicotine addiction in traditional cigarettes.

Redwood envisions being the pioneer in the market with a nicotine-free solution for addiction to nicotine in e-cigarettes or vape devices.

CEO Jason Cardiff expressed his sentiments, stating, "It has been a long road for us, and we are working around the clock to get these products on the market as fast as possible. We understand the urgency for help when it comes to the addiction of nicotine in vapes."

This conditional approval from IRB/CIRB signifies a crucial step forward for Redwood Scientific Technologies in its commitment to addressing nicotine addiction across various mediums. The company remains dedicated to accelerating the development and market availability of these groundbreaking solutions to make a meaningful impact on the current challenges associated with nicotine dependency.

For further information, please contact:

Media Relations
Redwood Scientific Technologies
Info@redwoodsci.co
646-503-7884

About Redwood Scientific Technologies:
Redwood Scientific Technologies is a leading research and development company based in New York, focused on innovative solutions to combat nicotine addiction. With a commitment to advancing healthcare, Redwood is dedicated to introducing groundbreaking products to improve the lives of individuals struggling with nicotine dependency.

View original content:https://www.prnewswire.com/news-releases/redwood-scientific-technologies-receives-conditional-approval-from-irbcirb-for-groundbreaking-clinical-studies-301987655.html

SOURCE REDWOOD SCIENTIFIC TECHNOLOGIES

FAQ

What milestone has Redwood Scientific Technologies achieved?

Redwood Scientific Technologies has secured conditional approval from the Institutional Review Board (IRB)/Central Institutional Review Board (CIRB) for groundbreaking clinical studies on a new Oral Thin Film Strip to address nicotine addiction in vape devices and TBX FREE for traditional cigarettes.

What products are Redwood Scientific Technologies focusing on in the clinical studies?

The company is focusing on a new Oral Thin Film Strip to address nicotine addiction in vape devices and TBX FREE for traditional cigarettes.

What is the CEO's sentiment about the conditional approval?

CEO Jason Cardiff expressed dedication to accelerating product development and market availability, understanding the urgency for help with nicotine addiction in vapes.

How can Redwood Scientific Technologies be contacted for further information?

For further information, please contact Media Relations at Redwood Scientific Technologies via email at info@redwoodsci.co or by phone at 646-503-7884.